Review



stat4  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology stat4
    Stat4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 286 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/Stat4+Antibody/pm41830859-93-46-48
    Average 93 stars, based on 286 article reviews
    stat4 - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses
    Article Snippet: .. Blots were probed with primary antibodies for ΔNp63 (1:1,000; #619002, BioLegend, RRID:AB_2207170), TAp63 (1:500; #938102, BioLegend, RRID:AB_2876758), Foxj2 (1:500; sc-514265, Santa Cruz Biotechnology, RRID:AB_2941799), Foxl1 (1:1,000; PA5–40518, Invitrogen, RRID:AB_2607990), Nrf2 (1:500; PA5–27882, Invitrogen, RRID:AB_2545358), Stat4 (1:1,000; sc-398228, Santa Cruz Biotechnology, RRID:AB_2810272), and Stat5a (1:1,000; 13–3600, Invitrogen, RRID:AB_2533013), at 4°C for 18 hours followed by incubation for 1 hour at room temperature with the appropriate secondary antibodies conjugated to horseradish peroxidase (1:5,000; Jackson Laboratory). .. Detection was performed using the ECL Plus Kit (Amersham) following the manufacturer's protocol and X-ray autoradiography.

    Article Title: Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses
    Article Snippet: .. Blots were probed with primary antibodies for ΔNp63 (1:1,000) (#619002, BioLegend, RRID:AB_2207170), TAp63 (1:500) (#938102, Biolegend, RRID:AB_2876758), Foxj2 (1:500) (sc-514265, Santa Cruz, RRID:AB_2941799), Foxl1 (1:1,000) (PA5-40518, Invitrogen, RRID:AB_2607990), Nrf2 (1:500) (PA5-27882, Invitrogen, RRID:AB_2545358), Stat4 (1:1,000) (sc-398228, Santa Cruz, RRID:AB_2810272), and Stat5a (1:1,000) (13-3600, Invitrogen, RRID:AB_2533013), at 4 °C for 18 h followed by incubation for 1 h at room temperature with the appropriate secondary antibodies conjugated to horseradish peroxidase (1:5,000) (Jackson Lab). .. Detection was performed using the ECL Plus Kit (Amersham) following the manufacturer’s protocol and X-ray autoradiography. siRNA transfection.

    Transduction:

    Article Title: Acetylation licenses Th1 cell polarization to constrain Listeria monocytogenes infection.
    Article Snippet: .. The following primary antibodies were commercially obtained: acetylatedlysine (9441; Cell Signaling Transduction), Stat4 pY693 (554002; BD Biosciences), Stat4 (sc-398228; Santa Cruz), Myc, HA, Flag (F7425; SigmaAldrich), CBP, HDAC6 (sc-5258; Santa Cruz), actin and Gapdh. ..

    Staining:

    Article Title: ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis
    Article Snippet: Flow antibodies used for human included: CD3 (clone OKT3, BioLegend), CD4 (clone OKT4, BioLegend), CD45RA (clone HI100, BioLegend), IFN-γ AF647 (clone 4S.B3, BioLegend), IL-17A PE (clone N49–653, BD Biosciences), IL-2 FITC (clone MQ1–17H12, BioLegend), IL-13 PECy7 (clone 5ES10–5A2, BioLegend), IL-4 PE (clone 8D4–8, BD Biosciences), FOXP3 PE (clone 236A/E7, eBioscience), and CD25 APC (clone 4E3, eBioscience). .. For mouse staining, the following antibodies were used: CD3 (clone 17A2, BioLegend), CD4 (clone GK1.5, BioLegend), IFN-γ PECy7 (clone XMG1.2, BD Biosciences), IL-17A PE (clone TC11–18H10.1, BioLegend), IL-2 APC (clone JES6–5H4, BioLegend), IL-4 Alexa488 (clone 11B11, BD Bioscience), IL-13 PE (clone W17010B, BioLegend), FOXP3 PE (clone MF23, eBioscience), CD25 APC (PC61.5, eBioscience), pSTAT3 Y705 PE (clone 13A3–1, BioLegend), and pSTAT4 PE (38/p-Stat4, BD Biosciences). .. siCTLTh17 and siZEB1Th17 cells (1 × 10 6 ) were sorted using BD FACSMelody and stained with the following cell hashing antibodies; siCTLTh17 day5 (Cat #394663, Biolegend), siZEB1Th17 day 5 (Cat #394667, Biolegend). scRNA-seq was performed using 10x Genomics Single Cell 5′ v1 workflow and processed according to the manufacturer’s instructions.

    Western Blot:

    Article Title: Defining genetic variation in widely used congenic and backcrossed mouse models reveals varied regulation of genes important for immune responses
    Article Snippet: .. Antibodies used in the western analysis were to Cxcr4 (Abcam, ab124824), cathepsin E (R&D, BAF1130), or as a control to STAT4 (Santa Cruz, C-20, sc-486X). .. UCSC genome browser and IGV browser ChIP-seq and RNA-seq data were displayed using the University of California Santa Cruz (UCSC) genome browser ( http://genome.ucsc.edu/ )( Kent et al., 2002 ) or the Integrative Genomics Viewer (IGV; Broad Institute; version 2.4.11) ( Robinson et al., 2011 ; Thorvaldsdottir et al., 2013 ).

    Control:

    Article Title: Defining genetic variation in widely used congenic and backcrossed mouse models reveals varied regulation of genes important for immune responses
    Article Snippet: .. Antibodies used in the western analysis were to Cxcr4 (Abcam, ab124824), cathepsin E (R&D, BAF1130), or as a control to STAT4 (Santa Cruz, C-20, sc-486X). .. UCSC genome browser and IGV browser ChIP-seq and RNA-seq data were displayed using the University of California Santa Cruz (UCSC) genome browser ( http://genome.ucsc.edu/ )( Kent et al., 2002 ) or the Integrative Genomics Viewer (IGV; Broad Institute; version 2.4.11) ( Robinson et al., 2011 ; Thorvaldsdottir et al., 2013 ).



    Similar Products

    94
    Cell Signaling Technology Inc phospho stat4 tyr693
    Phospho Stat4 Tyr693, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/Phospho-Stat4+(Tyr693)+Rabbit+mAb/pmc13673060-199-44-46
    Average 94 stars, based on 1 article reviews
    phospho stat4 tyr693 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc stat4
    IAAld suppresses Th1 and Th17 cell differentiation in an AhR‐dependent manner by repressing JAK/STAT signaling. (A) KEGG pathway enrichment analysis of the intersectional targets of IAAld and MS. (B) In silico prediction of the binding interaction between IAAld and AhR by molecular docking. The calculated binding energy (BE) is −6.6 kcal/mol (inset: chemical structure of IAAld). (C,D) Flow cytometric quantification and representative plots of CD4 + IFNγ + (Th1) and CD4 + IL‑17A + (Th17) cells under in vitro differentiation conditions across PBS, IAAld (10 µM), and IAAld+siAhR (AhR knockdown by siRNA) groups ( n = 3 per group). (E) Immunofluorescence staining of AhR (green) in Th1 and Th17 cells of each group, and cell nuclei were stained with DAPI (blue). (F) Western blot analysis showing protein levels of AhR, p‑JAK2, JAK2, p‑STAT4, <t>STAT4,</t> p‑STAT3, STAT3, SOCS1, SOCS3, and GAPDH in Th1 (left) and Th17 (right) cells. (G) Quantitative analysis of AhR/GAPDH ratio, p‐JAK2/JAK2 ratio, p‐STAT4/STAT4 ratio, p‐STAT3/STAT3 ratio, SOCS1/GAPDH ratio and SOCS3/GAPDH ratio in each group ( n = 4 per group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
    Stat4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/Stat4+Rabbit+mAb/pmc13673060-199-51-52
    Average 95 stars, based on 1 article reviews
    stat4 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    TargetMol stat4 inhibitor
    IAAld suppresses Th1 and Th17 cell differentiation in an AhR‐dependent manner by repressing JAK/STAT signaling. (A) KEGG pathway enrichment analysis of the intersectional targets of IAAld and MS. (B) In silico prediction of the binding interaction between IAAld and AhR by molecular docking. The calculated binding energy (BE) is −6.6 kcal/mol (inset: chemical structure of IAAld). (C,D) Flow cytometric quantification and representative plots of CD4 + IFNγ + (Th1) and CD4 + IL‑17A + (Th17) cells under in vitro differentiation conditions across PBS, IAAld (10 µM), and IAAld+siAhR (AhR knockdown by siRNA) groups ( n = 3 per group). (E) Immunofluorescence staining of AhR (green) in Th1 and Th17 cells of each group, and cell nuclei were stained with DAPI (blue). (F) Western blot analysis showing protein levels of AhR, p‑JAK2, JAK2, p‑STAT4, <t>STAT4,</t> p‑STAT3, STAT3, SOCS1, SOCS3, and GAPDH in Th1 (left) and Th17 (right) cells. (G) Quantitative analysis of AhR/GAPDH ratio, p‐JAK2/JAK2 ratio, p‐STAT4/STAT4 ratio, p‐STAT3/STAT3 ratio, SOCS1/GAPDH ratio and SOCS3/GAPDH ratio in each group ( n = 4 per group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.
    Stat4 Inhibitor, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/(R)-Lisofylline/pm41904509-314-13-19
    Average 94 stars, based on 1 article reviews
    stat4 inhibitor - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    TargetMol stat4 inhibitor r lisofylline t21694
    Chemotherapy-induced senescence of nasopharyngeal carcinoma cells upregulates EBI3 to promote IL35 secretion, thereby activating the STAT1-NKG2A signaling axis and affecting NK cell-mediated anti-tumor immunity. A The supernatants of NPC cells without cisplatin treatment, cisplatin-treated WT, and cisplatin-treated sgEBI3 were co-cultured with NK-92MI cells. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). B Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). C Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). D Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). E Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells with or without IL-35. RT-qPCR was used to analyze the mRNA levels of IL35R in NK-92MI cells ( n = 3 experiments). F Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 plus STAT1 inhibitors, and r-IL-35 plus <t>STAT4</t> inhibitors. The left image is a representative flow cytometry image, and the right image is a statistical graph ( n = 3 experiments). G RT-qPCR was used to detect the mRNA levels of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 + STAT1 inhibitors, and rIL35 + STAT4 inhibitors ( n = 3 experiments). H Schematic diagram of STAT1 binding in the NKG2A promoter region. I ChIP was used to detect the binding of STAT1 to the NKG2A promoter region ( n = 3 experiments). J Schematic diagram of the molecular mechanism by which IL-35 upregulates NKG2A expression in NK cells via activating the STAT1 signaling pathway through its receptor ( A - D , F - H , J ) data are expressed as mean ± SD; B , F , J A two-tailed unpaired t-test was used; A , C , D , G , H A two-tailed unpaired t-test or one-way analysis of variance (ANOVA) and Tukey’s post hoc test was used
    Stat4 Inhibitor R Lisofylline T21694, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/(R)-Lisofylline/pmc13151093-387-13-21
    Average 94 stars, based on 1 article reviews
    stat4 inhibitor r lisofylline t21694 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology stat4
    Chemotherapy-induced senescence of nasopharyngeal carcinoma cells upregulates EBI3 to promote IL35 secretion, thereby activating the STAT1-NKG2A signaling axis and affecting NK cell-mediated anti-tumor immunity. A The supernatants of NPC cells without cisplatin treatment, cisplatin-treated WT, and cisplatin-treated sgEBI3 were co-cultured with NK-92MI cells. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). B Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). C Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). D Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). E Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells with or without IL-35. RT-qPCR was used to analyze the mRNA levels of IL35R in NK-92MI cells ( n = 3 experiments). F Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 plus STAT1 inhibitors, and r-IL-35 plus <t>STAT4</t> inhibitors. The left image is a representative flow cytometry image, and the right image is a statistical graph ( n = 3 experiments). G RT-qPCR was used to detect the mRNA levels of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 + STAT1 inhibitors, and rIL35 + STAT4 inhibitors ( n = 3 experiments). H Schematic diagram of STAT1 binding in the NKG2A promoter region. I ChIP was used to detect the binding of STAT1 to the NKG2A promoter region ( n = 3 experiments). J Schematic diagram of the molecular mechanism by which IL-35 upregulates NKG2A expression in NK cells via activating the STAT1 signaling pathway through its receptor ( A - D , F - H , J ) data are expressed as mean ± SD; B , F , J A two-tailed unpaired t-test was used; A , C , D , G , H A two-tailed unpaired t-test or one-way analysis of variance (ANOVA) and Tukey’s post hoc test was used
    Stat4, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/Stat4+Antibody/pm41830859-93-46-48
    Average 93 stars, based on 1 article reviews
    stat4 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc anti stat4
    Chemotherapy-induced senescence of nasopharyngeal carcinoma cells upregulates EBI3 to promote IL35 secretion, thereby activating the STAT1-NKG2A signaling axis and affecting NK cell-mediated anti-tumor immunity. A The supernatants of NPC cells without cisplatin treatment, cisplatin-treated WT, and cisplatin-treated sgEBI3 were co-cultured with NK-92MI cells. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). B Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). C Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). D Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). E Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells with or without IL-35. RT-qPCR was used to analyze the mRNA levels of IL35R in NK-92MI cells ( n = 3 experiments). F Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 plus STAT1 inhibitors, and r-IL-35 plus <t>STAT4</t> inhibitors. The left image is a representative flow cytometry image, and the right image is a statistical graph ( n = 3 experiments). G RT-qPCR was used to detect the mRNA levels of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 + STAT1 inhibitors, and rIL35 + STAT4 inhibitors ( n = 3 experiments). H Schematic diagram of STAT1 binding in the NKG2A promoter region. I ChIP was used to detect the binding of STAT1 to the NKG2A promoter region ( n = 3 experiments). J Schematic diagram of the molecular mechanism by which IL-35 upregulates NKG2A expression in NK cells via activating the STAT1 signaling pathway through its receptor ( A - D , F - H , J ) data are expressed as mean ± SD; B , F , J A two-tailed unpaired t-test was used; A , C , D , G , H A two-tailed unpaired t-test or one-way analysis of variance (ANOVA) and Tukey’s post hoc test was used
    Anti Stat4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/Stat4+Rabbit+mAb/pm41826817-101-59-63
    Average 95 stars, based on 1 article reviews
    anti stat4 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti phospho stat4 tyr693
    Chemotherapy-induced senescence of nasopharyngeal carcinoma cells upregulates EBI3 to promote IL35 secretion, thereby activating the STAT1-NKG2A signaling axis and affecting NK cell-mediated anti-tumor immunity. A The supernatants of NPC cells without cisplatin treatment, cisplatin-treated WT, and cisplatin-treated sgEBI3 were co-cultured with NK-92MI cells. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). B Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). C Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). D Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). E Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells with or without IL-35. RT-qPCR was used to analyze the mRNA levels of IL35R in NK-92MI cells ( n = 3 experiments). F Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 plus STAT1 inhibitors, and r-IL-35 plus <t>STAT4</t> inhibitors. The left image is a representative flow cytometry image, and the right image is a statistical graph ( n = 3 experiments). G RT-qPCR was used to detect the mRNA levels of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 + STAT1 inhibitors, and rIL35 + STAT4 inhibitors ( n = 3 experiments). H Schematic diagram of STAT1 binding in the NKG2A promoter region. I ChIP was used to detect the binding of STAT1 to the NKG2A promoter region ( n = 3 experiments). J Schematic diagram of the molecular mechanism by which IL-35 upregulates NKG2A expression in NK cells via activating the STAT1 signaling pathway through its receptor ( A - D , F - H , J ) data are expressed as mean ± SD; B , F , J A two-tailed unpaired t-test was used; A , C , D , G , H A two-tailed unpaired t-test or one-way analysis of variance (ANOVA) and Tukey’s post hoc test was used
    Anti Phospho Stat4 Tyr693, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/Phospho-Stat4+(Tyr693)+Rabbit+mAb/pm41826817-101-69-74
    Average 94 stars, based on 1 article reviews
    anti phospho stat4 tyr693 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc antibodies against stat4
    Chemotherapy-induced senescence of nasopharyngeal carcinoma cells upregulates EBI3 to promote IL35 secretion, thereby activating the STAT1-NKG2A signaling axis and affecting NK cell-mediated anti-tumor immunity. A The supernatants of NPC cells without cisplatin treatment, cisplatin-treated WT, and cisplatin-treated sgEBI3 were co-cultured with NK-92MI cells. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). B Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). C Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). D Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). E Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells with or without IL-35. RT-qPCR was used to analyze the mRNA levels of IL35R in NK-92MI cells ( n = 3 experiments). F Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 plus STAT1 inhibitors, and r-IL-35 plus <t>STAT4</t> inhibitors. The left image is a representative flow cytometry image, and the right image is a statistical graph ( n = 3 experiments). G RT-qPCR was used to detect the mRNA levels of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 + STAT1 inhibitors, and rIL35 + STAT4 inhibitors ( n = 3 experiments). H Schematic diagram of STAT1 binding in the NKG2A promoter region. I ChIP was used to detect the binding of STAT1 to the NKG2A promoter region ( n = 3 experiments). J Schematic diagram of the molecular mechanism by which IL-35 upregulates NKG2A expression in NK cells via activating the STAT1 signaling pathway through its receptor ( A - D , F - H , J ) data are expressed as mean ± SD; B , F , J A two-tailed unpaired t-test was used; A , C , D , G , H A two-tailed unpaired t-test or one-way analysis of variance (ANOVA) and Tukey’s post hoc test was used
    Antibodies Against Stat4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/Stat4+Rabbit+mAb/pm41814359-137-13-18
    Average 95 stars, based on 1 article reviews
    antibodies against stat4 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    93
    Proteintech 13028-1-ap
    Chemotherapy-induced senescence of nasopharyngeal carcinoma cells upregulates EBI3 to promote IL35 secretion, thereby activating the STAT1-NKG2A signaling axis and affecting NK cell-mediated anti-tumor immunity. A The supernatants of NPC cells without cisplatin treatment, cisplatin-treated WT, and cisplatin-treated sgEBI3 were co-cultured with NK-92MI cells. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). B Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). C Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). D Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). E Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells with or without IL-35. RT-qPCR was used to analyze the mRNA levels of IL35R in NK-92MI cells ( n = 3 experiments). F Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 plus STAT1 inhibitors, and r-IL-35 plus <t>STAT4</t> inhibitors. The left image is a representative flow cytometry image, and the right image is a statistical graph ( n = 3 experiments). G RT-qPCR was used to detect the mRNA levels of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 + STAT1 inhibitors, and rIL35 + STAT4 inhibitors ( n = 3 experiments). H Schematic diagram of STAT1 binding in the NKG2A promoter region. I ChIP was used to detect the binding of STAT1 to the NKG2A promoter region ( n = 3 experiments). J Schematic diagram of the molecular mechanism by which IL-35 upregulates NKG2A expression in NK cells via activating the STAT1 signaling pathway through its receptor ( A - D , F - H , J ) data are expressed as mean ± SD; B , F , J A two-tailed unpaired t-test was used; A , C , D , G , H A two-tailed unpaired t-test or one-way analysis of variance (ANOVA) and Tukey’s post hoc test was used
    13028 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/stat4/STAT4+Antibody/bio_rxiv__64898__2026__02__03__703506-107-4-5
    Average 93 stars, based on 1 article reviews
    13028-1-ap - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    IAAld suppresses Th1 and Th17 cell differentiation in an AhR‐dependent manner by repressing JAK/STAT signaling. (A) KEGG pathway enrichment analysis of the intersectional targets of IAAld and MS. (B) In silico prediction of the binding interaction between IAAld and AhR by molecular docking. The calculated binding energy (BE) is −6.6 kcal/mol (inset: chemical structure of IAAld). (C,D) Flow cytometric quantification and representative plots of CD4 + IFNγ + (Th1) and CD4 + IL‑17A + (Th17) cells under in vitro differentiation conditions across PBS, IAAld (10 µM), and IAAld+siAhR (AhR knockdown by siRNA) groups ( n = 3 per group). (E) Immunofluorescence staining of AhR (green) in Th1 and Th17 cells of each group, and cell nuclei were stained with DAPI (blue). (F) Western blot analysis showing protein levels of AhR, p‑JAK2, JAK2, p‑STAT4, STAT4, p‑STAT3, STAT3, SOCS1, SOCS3, and GAPDH in Th1 (left) and Th17 (right) cells. (G) Quantitative analysis of AhR/GAPDH ratio, p‐JAK2/JAK2 ratio, p‐STAT4/STAT4 ratio, p‐STAT3/STAT3 ratio, SOCS1/GAPDH ratio and SOCS3/GAPDH ratio in each group ( n = 4 per group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: Advanced Science

    Article Title: Gut Microbiota‐Derived Indole‐3‐Acetaldehyde Contributes to the Disease‐Alleviating Effects of Kurarinone in Experimental Autoimmune Encephalomyelitis

    doi: 10.1002/advs.78358

    Figure Lengend Snippet: IAAld suppresses Th1 and Th17 cell differentiation in an AhR‐dependent manner by repressing JAK/STAT signaling. (A) KEGG pathway enrichment analysis of the intersectional targets of IAAld and MS. (B) In silico prediction of the binding interaction between IAAld and AhR by molecular docking. The calculated binding energy (BE) is −6.6 kcal/mol (inset: chemical structure of IAAld). (C,D) Flow cytometric quantification and representative plots of CD4 + IFNγ + (Th1) and CD4 + IL‑17A + (Th17) cells under in vitro differentiation conditions across PBS, IAAld (10 µM), and IAAld+siAhR (AhR knockdown by siRNA) groups ( n = 3 per group). (E) Immunofluorescence staining of AhR (green) in Th1 and Th17 cells of each group, and cell nuclei were stained with DAPI (blue). (F) Western blot analysis showing protein levels of AhR, p‑JAK2, JAK2, p‑STAT4, STAT4, p‑STAT3, STAT3, SOCS1, SOCS3, and GAPDH in Th1 (left) and Th17 (right) cells. (G) Quantitative analysis of AhR/GAPDH ratio, p‐JAK2/JAK2 ratio, p‐STAT4/STAT4 ratio, p‐STAT3/STAT3 ratio, SOCS1/GAPDH ratio and SOCS3/GAPDH ratio in each group ( n = 4 per group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: SDS loading buffer (Deeyeebio, 50053) was added to the cell lysis solution, and the proteins (30 μg/lane) were separated by SDS‐PAGE and transferred onto the PVDF membrane, and probed with primary antibodies against phospho‐JAK2 (Tyr1007/1008) (CST, 3771), JAK2 (CST, 3230), phospho‐STAT3 (Ser705) (CST, 9145), phospho‐STAT4 (Tyr693) (CST, 4134), STAT3 (Proteintech, 10253‐2‐ap), STAT4 (CST, 2653), SOCS1 (CST, 55313), SOCS3 (Proteintech, 14025‐1‐ap), and AhR (Proteintech, 67785‐1‐lg), followed by HRP‐conjugated secondary antibodies (Proteintech, SA00001‐1, SA00001‐2).

    Techniques: Cell Differentiation, Analysis, In Silico, Binding Assay, Docking Assay, In Vitro, Knockdown, Immunofluorescence, Staining, Western Blot, Significance Assay

    Graphical abstract. Schematic diagram illustrating the molecular mechanism by which KU ameliorates EAE through the gut microbiota‐IAAld‐AhR axis. KU reshapes gut microbiota composition in EAE mice, specifically increasing the abundance of Akkermansia muciniphila . A. muciniphila facilitates intestinal production of indole‐3‐acetaldehyde (IAAld) and the latter crosses the intestinal barrier to enter peripheral circulation and CNS, where IAAld activates AhR and promotes its nuclear translocation in CD4 + T cells. Once in the nucleus, activated AhR upregulates SOCS1 and SOCS3 expression and suppresses phosphorylation of JAK2 and its downstream targets, STAT4 and STAT3. This cascade restrains CD4 + T cell differentiation into Th1 and Th17 subsets, ultimately mitigating CNS inflammation and demyelination in EAE mice.

    Journal: Advanced Science

    Article Title: Gut Microbiota‐Derived Indole‐3‐Acetaldehyde Contributes to the Disease‐Alleviating Effects of Kurarinone in Experimental Autoimmune Encephalomyelitis

    doi: 10.1002/advs.78358

    Figure Lengend Snippet: Graphical abstract. Schematic diagram illustrating the molecular mechanism by which KU ameliorates EAE through the gut microbiota‐IAAld‐AhR axis. KU reshapes gut microbiota composition in EAE mice, specifically increasing the abundance of Akkermansia muciniphila . A. muciniphila facilitates intestinal production of indole‐3‐acetaldehyde (IAAld) and the latter crosses the intestinal barrier to enter peripheral circulation and CNS, where IAAld activates AhR and promotes its nuclear translocation in CD4 + T cells. Once in the nucleus, activated AhR upregulates SOCS1 and SOCS3 expression and suppresses phosphorylation of JAK2 and its downstream targets, STAT4 and STAT3. This cascade restrains CD4 + T cell differentiation into Th1 and Th17 subsets, ultimately mitigating CNS inflammation and demyelination in EAE mice.

    Article Snippet: SDS loading buffer (Deeyeebio, 50053) was added to the cell lysis solution, and the proteins (30 μg/lane) were separated by SDS‐PAGE and transferred onto the PVDF membrane, and probed with primary antibodies against phospho‐JAK2 (Tyr1007/1008) (CST, 3771), JAK2 (CST, 3230), phospho‐STAT3 (Ser705) (CST, 9145), phospho‐STAT4 (Tyr693) (CST, 4134), STAT3 (Proteintech, 10253‐2‐ap), STAT4 (CST, 2653), SOCS1 (CST, 55313), SOCS3 (Proteintech, 14025‐1‐ap), and AhR (Proteintech, 67785‐1‐lg), followed by HRP‐conjugated secondary antibodies (Proteintech, SA00001‐1, SA00001‐2).

    Techniques: Translocation Assay, Expressing, Phospho-proteomics, Cell Differentiation

    Chemotherapy-induced senescence of nasopharyngeal carcinoma cells upregulates EBI3 to promote IL35 secretion, thereby activating the STAT1-NKG2A signaling axis and affecting NK cell-mediated anti-tumor immunity. A The supernatants of NPC cells without cisplatin treatment, cisplatin-treated WT, and cisplatin-treated sgEBI3 were co-cultured with NK-92MI cells. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). B Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). C Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). D Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). E Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells with or without IL-35. RT-qPCR was used to analyze the mRNA levels of IL35R in NK-92MI cells ( n = 3 experiments). F Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 plus STAT1 inhibitors, and r-IL-35 plus STAT4 inhibitors. The left image is a representative flow cytometry image, and the right image is a statistical graph ( n = 3 experiments). G RT-qPCR was used to detect the mRNA levels of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 + STAT1 inhibitors, and rIL35 + STAT4 inhibitors ( n = 3 experiments). H Schematic diagram of STAT1 binding in the NKG2A promoter region. I ChIP was used to detect the binding of STAT1 to the NKG2A promoter region ( n = 3 experiments). J Schematic diagram of the molecular mechanism by which IL-35 upregulates NKG2A expression in NK cells via activating the STAT1 signaling pathway through its receptor ( A - D , F - H , J ) data are expressed as mean ± SD; B , F , J A two-tailed unpaired t-test was used; A , C , D , G , H A two-tailed unpaired t-test or one-way analysis of variance (ANOVA) and Tukey’s post hoc test was used

    Journal: Cell Communication and Signaling : CCS

    Article Title: Chemotherapy-induced senescent nasopharyngeal carcinoma cells suppress NK cell-mediated antitumor immunity by upregulating EBI3 via mtDNA-cGAS-STING pathway

    doi: 10.1186/s12964-026-02848-6

    Figure Lengend Snippet: Chemotherapy-induced senescence of nasopharyngeal carcinoma cells upregulates EBI3 to promote IL35 secretion, thereby activating the STAT1-NKG2A signaling axis and affecting NK cell-mediated anti-tumor immunity. A The supernatants of NPC cells without cisplatin treatment, cisplatin-treated WT, and cisplatin-treated sgEBI3 were co-cultured with NK-92MI cells. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). B Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. RT-qPCR was used to analyze the mRNA levels of activating and inhibitory receptors in NK-92MI cells ( n = 3 experiments). C Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). D Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells in the presence or absence of r-IL-35. Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells. The upper figure is a representative image of flow cytometry, and the lower figure is a statistical chart ( n = 3 experiments). E Cisplatin-induced sgEBI3 NPC cells were co-cultured with NK-92MI cells with or without IL-35. RT-qPCR was used to analyze the mRNA levels of IL35R in NK-92MI cells ( n = 3 experiments). F Flow cytometry was used to detect the expression of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 plus STAT1 inhibitors, and r-IL-35 plus STAT4 inhibitors. The left image is a representative flow cytometry image, and the right image is a statistical graph ( n = 3 experiments). G RT-qPCR was used to detect the mRNA levels of NKG2A in NK-92MI cells treated with control, r-IL-35, r-IL-35 + STAT1 inhibitors, and rIL35 + STAT4 inhibitors ( n = 3 experiments). H Schematic diagram of STAT1 binding in the NKG2A promoter region. I ChIP was used to detect the binding of STAT1 to the NKG2A promoter region ( n = 3 experiments). J Schematic diagram of the molecular mechanism by which IL-35 upregulates NKG2A expression in NK cells via activating the STAT1 signaling pathway through its receptor ( A - D , F - H , J ) data are expressed as mean ± SD; B , F , J A two-tailed unpaired t-test was used; A , C , D , G , H A two-tailed unpaired t-test or one-way analysis of variance (ANOVA) and Tukey’s post hoc test was used

    Article Snippet: IKK inhibitor (BAY11-7082) (T1902), cGAS inhibitor (RU.521) (T5486), STAT1 inhibitor (Fludarabine) (T1038), and STAT4 inhibitor ((R)-Lisofylline)( T21694 ) were purchased from TargetMol, China.

    Techniques: Cell Culture, Quantitative RT-PCR, Flow Cytometry, Expressing, Control, Binding Assay, Two Tailed Test